Ciprofloxacin treatment in vivo increases the ex vivo capacity of lipopolysaccharide-stimulated human monocytes to produce IL-1, IL-6 and tumour necrosis factor-alpha.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples